Intangible Assets, Net

12 Months Ended

Dec. 31, 2024

The following tables present details of our intangible assets, net:


	December 31, 2024
(dollars in thousands)	Useful Life (in years)	Gross Carrying Amount	Accumulated Amortization	Net Carrying Amount	Weighted Average Remaining Useful Life (in years)
Customer relationships	9-13	$75,500	$(25,828)	$49,672	7.7
Developed technology	1-5	56,298	(54,297)	2,001	1.8
Trademarks	1-9	12,716	(12,287)	429	4.6
Content library	3	9,500	(9,500)	—	0.0
		$154,014	$(101,912)	$52,102	7.4


	December 31, 2023
(dollars in thousands)	Useful Life (in years)	Gross Carrying Amount	Accumulated Amortization	Net Carrying Amount	Weighted Average Remaining Useful Life (in years)
Customer relationships	9-13	$75,500	$(19,223)	$56,277	8.7
Developed technology	1-5	56,298	(53,157)	3,141	2.8
Trademarks	1-9	12,716	(12,159)	557	5.3
Content library	3	9,500	(8,577)	923	0.3
		$154,014	$(93,116)	$60,898	8.2

For the years ended December 31, 2024, 2023 and 2022, amortization expense was $8.8 million, $59.0 million and

$23.2 million, respectively. Amortization of intangible assets acquired in connection with vitaCare was accelerated during the

year ended December 31, 2023 as we de-prioritized certain solutions under our pharma manufacturer solutions platform for

which these intangible assets supported. See "Note 17. Restructuring" for additional information.

At December 31, 2024, the expected amortization of intangible assets, net for future periods was as follows: